Trials / Recruiting
RecruitingNCT03883022
Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Taipei Veterans General Hospital, Taiwan · Other Government
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Deep surgical site infection (DSSI) is one of the most challenging complications for spinal surgeons and can lead to a poor clinical outcome. This ambispective study was designed to examine the effect of vancomycin powder mixed with autogenous bone graft and bone substitute on preventing deep surgical site infection (DSSI) in degenerative lumbar fusion surgeries as well as any interference with bony fusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | with U-VANCO (vancomycin hydrochloride) | 1 gm or 2 gm mixed with autogenous cancellous bone graft |
| DRUG | without U-VANCO (vancomycin hydrochloride) | no vancomycin added |
Timeline
- Start date
- 2018-09-03
- Primary completion
- 2027-09-12
- Completion
- 2027-12-31
- First posted
- 2019-03-20
- Last updated
- 2019-03-20
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03883022. Inclusion in this directory is not an endorsement.